LitCovid-sentences  

PMC:7242007 / 3545-7453 JSONTXT 10 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T33 0-50 Sentence denotes Table 1 SARS‐CoV‐2/COVID‐19 and Hepatitis B and C
T34 51-129 Sentence denotes Authors Infection Study Characteristics Observations Unique Considerations
T35 130-141 Sentence denotes Chen et al.
T36 142-293 Sentence denotes 10 HBV Retrospective analysis of hospitalized patients with COVID‐19 in a single center in Wuhan, China 12.2% (15/123) of patients were HBV infected
T37 294-379 Sentence denotes A higher percentage with comorbid HBV developed a severe outcome (46.7% versus 24.1%)
T38 380-442 Sentence denotes Total bilirubin level was higher in patients with comorbid HBV
T39 443-632 Sentence denotes Patients with comorbid HBV had a higher mortality rate (13.3% versus 2.8%) Heterogeneous data on the prevalence of HBV infection in COVID‐19 and on the interaction between HBV and COVID‐19
T40 633-731 Sentence denotes Risk for HBV reactivation with some experimental COVID‐19 therapies (tocilizumab, corticosteroids)
T41 732-850 Sentence denotes Some investigational COVID‐19 medications may be contraindicated in HBV‐infected patients with decompensated cirrhosis
T42 851-861 Sentence denotes Zha et al.
T43 862-1031 Sentence denotes 11 Observational study investigating the efficacy of corticosteroid treatment in hospitalized patients with COVID‐19 in China 6.5% (2/31) of patients were HBV infected
T44 1032-1106 Sentence denotes Association found between HBV infection and prolonged SARS‐CoV‐2 clearance
T45 1107-1124 Sentence denotes Richardson et al.
T46 1125-1271 Sentence denotes 8 Case series of hospitalized patients with COVID‐19 in 12 hospitals in the New York City metro area 0.1% (8/5700) of patients were HBV infected
T47 1272-1283 Sentence denotes Guan et al.
T48 1284-1415 Sentence denotes 9 Retrospective multicenter analysis of hospitalized patients with COVID‐19 in China 2.1% (23/1099) of patients were HBV infected
T49 1416-1501 Sentence denotes HBV‐infected individuals represented 2.4% of nonsevere cases and 0.6% of severe cases
T50 1502-1519 Sentence denotes Richardson et al.
T51 1520-1733 Sentence denotes 8 HCV Case series of hospitalized patients with COVID‐19 in 12 hospitals in the New York City metro area <0.1% (3/5700) of patients were HCV infected Low incidence of HCV in hospitalized patients with COVID‐19
T52 1734-1805 Sentence denotes No studies to date have reported the effect of HCV on COVID‐19 outcomes
T53 1806-1923 Sentence denotes Some investigational COVID‐19 medications may be contraindicated in patients with HCV‐related decompensated cirrhosis
T54 1924-1937 Sentence denotes Blanco et al.
T55 1938-2068 Sentence denotes 12 HIV Clinical case series of 5 hospitalized COVID‐19 patients in a single center in Spain 0.92% of patients were HIV infected
T56 2069-2142 Sentence denotes 0 died, 2 were admitted to the ICU (1 remained in the ICU at publication)
T57 2143-2263 Sentence denotes ART regimens adapted to protease inhibitor in all patients Low incidence of hospitalized patients with COVID‐19 and HIV
T58 2264-2290 Sentence denotes ART may need to be adapted
T59 2291-2482 Sentence denotes Although no studies have investigated COVID‐19 in PWIDs, that population has risk factors for severe disease course, including weaker immune system, cardiac pathology, and renal insufficiency
T60 2483-2563 Sentence denotes Heterogeneous data on time to antibody response and time to clinical improvement
T61 2564-2574 Sentence denotes Zhu et al.
T62 2575-2674 Sentence denotes 13 Case study in China in a HIV/SARS‐CoV‐2 co‐infected patient Comorbid diabetes and heavy smoker
T63 2675-2740 Sentence denotes Antibody/antigen test gave positive HIV results (no previous ART)
T64 2741-2752 Sentence denotes Chen et al.
T65 2753-2851 Sentence denotes 15 Case study in China in a patient co‐infected with HIV/SARS‐CoV‐2 Nonsevere COVID‐19 pneumonia
T66 2852-2916 Sentence denotes Had ongoing ART HIV treatment (tenofovir, lamivudine, efavirenz)
T67 2917-2968 Sentence denotes After COVID‐19 diagnosis, given lopinavir/ritonavir
T68 2969-3035 Sentence denotes Shortened disease course and quick resolution of pulmonary lesions
T69 3036-3048 Sentence denotes Aydin et al.
T70 3049-3240 Sentence denotes 14 Case series of 4 patients co‐infected with HIV/SARS‐CoV‐2 in Turkey In limited cases, study highlighted that COVID‐19 infection improved in cases using regular ART with viral suppression
T71 3241-3282 Sentence denotes One patient died of sudden cardiac arrest
T72 3283-3403 Sentence denotes Resolution of radiological findings and time to antibody formation were similar to HIV‐uninfected patients with COVID‐19
T73 3404-3415 Sentence denotes Zhao et al.
T74 3416-3553 Sentence denotes 16 HCV+HIV Case study in China of HIV/HCV co‐infected patient with COVID‐19 Negative SARS‐CoV‐2 RNA test and delayed antibody response
T75 3554-3577 Sentence denotes Was taking anti‐HIV ART
T76 3578-3725 Sentence denotes John Wiley & Sons, Ltd This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response.
T77 3726-3908 Sentence denotes It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.